<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-10</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-10</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>26</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é«˜åˆ†è¾¨ç‡è‚ºéƒ¨ç©ºé—´å•ç»†èƒå›¾è°±å‘å¸ƒï¼Œæ­ç¤ºæ…¢é˜»è‚ºæ—©æœŸç»†èƒç»„æˆå¤±è¡¡ä¸ç©ºé—´åˆ†å¸ƒå¼‚å¸¸ï¼›æ•´åˆè‡ªå™¬ã€è¡°è€ã€çº¿ç²’ä½“åŠŸèƒ½ç­‰å¤šçƒ­ç‚¹æ„å»ºè‚¿ç˜¤æ¨¡å‹ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- CARå…ç–«ç»†èƒæ²»ç–—çš„åŸºå› é€’é€ç­–ç•¥<br />
- Tç»†èƒå¹²æ€§é‡å¡‘å¯¹æŠ—è‚¿ç˜¤<br />
- å¼“å½¢è™«æ„ŸæŸ“çš„ç»†èƒå…ç–«åº”ç­”</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å¤šæ¨¡æ€ç©ºé—´ç»„å­¦æ­ç¤ºè‚ºå‰é©±ç—…å˜ä¸­ç»†èƒä¸å¾®ç¯å¢ƒçš„ååŒæ¼”å˜<br />
- ç™¾ç§æœºå™¨å­¦ä¹ ä¸å•ç»†èƒã€æ— ç›‘ç£èšç±»ç»“åˆçš„ç”Ÿä¿¡åˆ†ææ¨¡æ¿</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
VGLL1 åœ¨å‘è‚²æ»‹å…»å±‚ç»†èƒçš„è½¬å½•ç»„å’Œè¡¨è§‚åŸºå› ç»„ä¸­æ‰®æ¼”å…³é”®è§’è‰²ï¼Œé€šè¿‡ ChIP-Seqã€ATAC-Seq å’Œ RNA-Seq å¤šç»´åº¦æ­ç¤ºå…¶è°ƒæ§æœºåˆ¶ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢è®¨ VGLL1 å¯¹å‘è‚²æ»‹å…»å±‚ç»†èƒè½¬å½•ç»„å’Œè¡¨è§‚åŸºå› ç»„çš„å½±å“ã€‚<br />
- ç ”ç©¶å¿ƒè„è¡°ç«­ä¸­æˆçº¤ç»´ç»†èƒæ´»åŒ–å—ä½ç½®å’Œç—…å› çš„å½±å“ã€‚<br />
- åˆ†æé•æš´éœ²å¯¹çš®è‚¤ä¸Šçš®ç»†èƒçš„å•ç»†èƒå“åº”ã€‚<br />
- æ­ç¤º Licochalcone B é€šè¿‡é¶å‘ FTO ç¼“è§£å…‹ç½—æ©ç—…æŸä¼¤çš„æœºåˆ¶ã€‚<br />
- æ¢ç´¢å†…å«å­ RNA ç»“æ„åœ¨åŸºå› è¾“å‡ºæ§åˆ¶ä¸­çš„ä½œç”¨ã€‚<br />
- ç ”ç©¶ç»„è›‹ç™½å˜ä½“ H2BE åœ¨å¤§è„‘ä¸­å¯¹å¹´é¾„å’Œç»†èƒç±»å‹çš„ç‰¹å¼‚æ€§å½±å“ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æ•´åˆ ChIP-Seqã€ATAC-Seq å’Œ RNA-Seq æŠ€æœ¯ï¼Œå…¨é¢è§£æ VGLL1 çš„è°ƒæ§ç½‘ç»œã€‚<br />
- åˆ©ç”¨å•ç»†èƒæµ‹åºæŠ€æœ¯æ·±å…¥ç ”ç©¶çš®è‚¤å¯¹é•æŒ‘æˆ˜çš„ç²¾ç»†å“åº”ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (16æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>åˆšåˆšå‘è¡¨7.5åˆ†ç”Ÿä¿¡ï¼Œèšç„¦æ–°çƒ­ç‚¹æ£•æ¦ˆé…°åŒ–ï¼Œå•ç»†èƒ+æ— ç›‘ç£èšç±»+ç™¾ç§æœºå™¨å­¦ä¹ +ç®€å•éªŒè¯ã€‚éè‚¿ç˜¤ç”Ÿä¿¡æ¨¡æ¿ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å•ç»†èƒã€ç”Ÿä¿¡ã€èšç±»<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503913&amp;idx=1&amp;sn=515e37c638dbba56213a001a845fe510" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>éŸ©é›ªç¥¥å›¢é˜ŸTrends in Molecular Medicineç»¼è¿° | CARå…ç–«ç»†èƒæ²»ç–—çš„åŸºå› é€’é€ä¹‹è·¯</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šCellPresså…¨ç§‘å­¦<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€TMEã€scRNAã€scDNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè¿™äº›è¿›æ­¥å°†å…±åŒæ¨åŠ¨CARç–—æ³•æœ€ç»ˆæƒ åŠæ›´å¤šæ‚£è€…ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657285&amp;idx=3&amp;sn=7902c367a55960e1a452fa15a5a70939" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>æœ€æ–°7.5åˆ†ç”Ÿä¿¡ï¼Œä½œè€…æ•´åˆè‡ªå™¬+è¡°è€+ä¼‘çœ +çº¿ç²’ä½“åŠŸèƒ½+è‚¿ç˜¤å¹²æ€§è¿›è¡Œæ¨¡å‹æ„å»ºåŠéªŒè¯ã€‚è¿™ä¹ˆå¤šçƒ­ç‚¹ç»“åˆè¿˜æ˜¯ç¬¬ä¸€å›è§ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247492996&amp;idx=1&amp;sn=f4e3e84f49ef5f6c23e4f7ceb2534aad" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>ç‹å‡Œåå›¢é˜Ÿæ–°å‘Cancer Cellï¼Œé¡¶åˆŠç”Ÿä¿¡åˆ†æå’Œç»˜å›¾å­¦ä¹ </strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡é’±åŒå­¦<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‹æ·©åç”Ÿä¿¡å¤§ä½¬çš„ç”Ÿä¿¡æ–‡ç« ä»£ç éƒ½å¾ˆå¥½<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495468&amp;idx=1&amp;sn=6ca6058769db621a63ed4d08535a5c51" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>ä¸‰ç§æ–¹æ³•è§£å†³KEGGåŠŸèƒ½å¯Œé›†æ€»æ˜¯å‡ºç°çš„æ–­ç½‘æŠ¥é”™ï¼šcannot read from connection</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡æŠ€èƒ½æ ‘<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€å¯Œé›†<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæœ€è¿‘ç¾¤é‡Œé—®çš„æ¯”è¾ƒå¤šçš„é—®é¢˜å¦‚ä¸‹ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247546825&amp;idx=1&amp;sn=dd48f92032cc08b1adfca99f6b7f7e96" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>æµ™å¤§é™ˆæ·‘æ´å›¢é˜ŸTrends in Cancerç»¼è¿° | é‡å¡‘Tç»†èƒå¹²æ€§å¯¹æŠ—è‚¿ç˜¤</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šCellPresså…¨ç§‘å­¦<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€cancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè¯¥ç ”ç©¶æœ‰æœ›æ›´ç³»ç»Ÿåœ°æ­ç¤ºTpexç»†èƒåœ¨ä¸åŒä¸´åºŠèƒŒæ™¯ä¸‹çš„åŠ¨æ€å˜åŒ–ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657285&amp;idx=1&amp;sn=c5cb2926057feccc7f8d2626073febd7" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>å•ç»†èƒç©ºé—´å¤–æ˜¾å­--å¤šæ¨¡æ€ç©ºé—´ç»„å­¦æ­ç¤ºè‚ºå‰é©±ç—…å˜è¿›å±•ä¸­è‚ºæ³¡ç¥–ç»†èƒä¸ä¿ƒç‚å¾®ç¯å¢ƒçš„ååŒæ¼”å˜</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒç©ºé—´äº¤å“ä¹<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç©ºé—´ç»„å­¦<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šå•ç»†èƒç©ºé—´å¤–æ˜¾å­--å¤šæ¨¡æ€ç©ºé—´ç»„å­¦æ­ç¤ºè‚ºå‰é©±ç—…å˜è¿›å±•ä¸­è‚ºæ³¡ç¥–ç»†èƒä¸ä¿ƒç‚å¾®ç¯å¢ƒçš„ååŒæ¼”å˜<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498821&amp;idx=1&amp;sn=93c39b39e3cf529cbfdd11715b33a422" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>å› ä¸ºåŠæ‡‚ä¸æ‡‚æ‰€ä»¥æ›´å¥½å‘å•ç»†èƒæ•°æ®æŒ–æ˜æ–‡ç« ï¼ˆESM1ç‰¹å¼‚æ€§çš„å†…çš®ç»†èƒï¼Ÿï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒ<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533558&amp;idx=1&amp;sn=cff5f3c2733b97dbbc8a266d820e004d" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>è¯¦è§£ï¼šä¹™é…°è¾…é…¶ Aï¼ˆAcetyl-CoAï¼‰ä»£è°¢</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå°æä»£è°¢<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šå…¶åœ¨è‚¿ç˜¤å¾®ç¯å¢ƒä¸­çš„ä»£è°¢åŠ¨æ€ï¼Œä¸ä»…å½±å“ç€ç™Œç»†èƒè‡ªèº«çš„å¢æ®–å’Œç”Ÿå­˜ï¼Œè¿˜æ·±åˆ»è°ƒæ§ç€æŠ—è‚¿ç˜¤å…ç–«ååº”çš„å¼ºåº¦å’Œæ–¹å‘ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484018&amp;idx=1&amp;sn=4e6d9d70fa0350671654754192e0a1f8" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>åŸºå› ç»„å¯è§†åŒ–ç»†èŠ‚ä¼˜åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šè€ä¿Šä¿Šçš„ç”Ÿä¿¡ç¬”è®°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkyMTI1MTYxNA==&amp;mid=2247519755&amp;idx=1&amp;sn=1b96cb5b50983d526ec47127ffb2be8a" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 6 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (10æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE295124 VGLL1 å¯¹å‘è‚²ä¸­çš„æ»‹å…»å±‚ç»†èƒçš„è½¬å½•ç»„å’Œè¡¨è§‚åŸºå› ç»„å‡æœ‰è´¡çŒ® [ChIP-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ruben I Calderon ; Nirvay Sah ; Molly Huang ; Ryan H Kittle ; Walee B Shaik ; Jennifer N Chousal ; Sampada Kallol ; Tony Bui ; Robert Morey ; Alexandra Mitre ; Norah M Fogarty ; Claudia Gerri ; Claire Zheng ; Peter DeHoff ; Pratik Home ; Kathy K Niakan ; Heidi Cook-Andersen ; Kathleen M Fisch ; Soumen Paul ; Francesca SoncinSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensThe trophectoderm (TE), the outer layer of the blastocyst, is the first lineage specified during mammalian development. It initiates attachment and implantation into the maternal endometrium and gives rise to trophoblasts, the epithelial cells of the placenta that support development in utero. Animal models have identified key signaling pathways, including BMP, WNT, and HIPPO, that regulate extra-embryonic ectoderm development, but species-specific differences in regulatory networks underlying TE specification and placental development emphasize the need for human-specific models. We were the first to previously identify Vestigial-like Family Member 1 (VGLL1), a coactivator of the TEAD family of transcription factors, as a human-specific placental marker highly expressed in first trimester trophoblast progenitors. The HIPPO signaling pathway effector TEAD4 in complex with YAP1 regulates initial TE specification by acting on key TE transcription factors (TEtra factors): GATA2, GATA3, TFAP2A, and TFAP2C. Pluripotent stem cells (PSCs) represent a unique resource to study species-specific genetic and epigenetic mechanisms of TE and trophoblast development. Here, we use a PSC model in which BMP4 treatment and WNT inhibition (via IWP2) induce TE-like cells. We examined BMP4-dependent chromatin accessibility during the transition from PSC to TE-like cells in relation to gene expression and WNT activation. We found that BMP4 drives chromatin remodeling toward a trophoblast identity and that mesoderm genes are only transiently expressed with canonical WNT activation. Using this model, we determined that, while VGLL1 expression activation is temporally downstream of the TEtra factors, it is necessary for complete trophoblast differentiation by regulating EGFR expression and reinforcing GATA3 activation through positive feedback. We also found that VGLL1 enhanced canonical WNT signaling by directly regulating WNT receptors and effector genes. Furthermore, we identified KDM6B as a direct target of VGLL1. As a chromatin remodeler, KDM6...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295124" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE295121 VGLL1 å¯¹å‘è‚²ä¸­çš„æ»‹å…»å±‚ç»†èƒçš„è½¬å½•ç»„å’Œè¡¨è§‚åŸºå› ç»„å‡æœ‰è´¡çŒ® [ATAC-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ruben I Calderon ; Nirvay Sah ; Molly Huang ; Ryan H Kittle ; Walee B Shaik ; Jennifer N Chousal ; Sampada Kallol ; Tony Bui ; Robert Morey ; Alexandra Mitre ; Norah M Fogarty ; Claudia Gerri ; Claire Zheng ; Peter DeHoff ; Pratik Home ; Kathy K Niakan ; Heidi Cook-Andersen ; Kathleen M Fisch ; Soumen Paul ; Francesca SoncinSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensThe trophectoderm (TE), the outer layer of the blastocyst, is the first lineage specified during mammalian development. It initiates attachment and implantation into the maternal endometrium and gives rise to trophoblasts, the epithelial cells of the placenta that support development in utero. Animal models have identified key signaling pathways, including BMP, WNT, and HIPPO, that regulate extra-embryonic ectoderm development, but species-specific differences in regulatory networks underlying TE specification and placental development emphasize the need for human-specific models. We were the first to previously identify Vestigial-like Family Member 1 (VGLL1), a coactivator of the TEAD family of transcription factors, as a human-specific placental marker highly expressed in first trimester trophoblast progenitors. The HIPPO signaling pathway effector TEAD4 in complex with YAP1 regulates initial TE specification by acting on key TE transcription factors (TEtra factors): GATA2, GATA3, TFAP2A, and TFAP2C. Pluripotent stem cells (PSCs) represent a unique resource to study species-specific genetic and epigenetic mechanisms of TE and trophoblast development. Here, we use a PSC model in which BMP4 treatment and WNT inhibition (via IWP2) induce TE-like cells. We examined BMP4-dependent chromatin accessibility during the transition from PSC to TE-like cells in relation to gene expression and WNT activation. We found that BMP4 drives chromatin remodeling toward a trophoblast identity and that mesoderm genes are only transiently expressed with canonical WNT activation. Using this model, we determined that, while VGLL1 expression activation is temporally downstream of the TEtra factors, it is necessary for complete trophoblast differentiation by regulating EGFR expression and reinforcing GATA3 activation through positive feedback. We also found that VGLL1 enhanced canonical WNT signaling by directly regulating WNT receptors and effector genes. Furthermore, we identified KDM6B as a direct target of VGLL1. As a chromatin remodeler, KDM6...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295121" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE295126 VGLL1 å¯¹å‘è‚²ä¸­çš„æ»‹å…»å±‚ç»†èƒçš„è½¬å½•ç»„å’Œè¡¨è§‚åŸºå› ç»„å‡æœ‰è´¡çŒ® [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ruben I Calderon ; Nirvay Sah ; Molly Huang ; Ryan H Kittle ; Walee B Shaik ; Jennifer N Chousal ; Sampada Kallol ; Tony Bui ; Robert Morey ; Alexandra Mitre ; Norah M Fogarty ; Claudia Gerri ; Claire Zheng ; Peter DeHoff ; Pratik Home ; Kathy K Niakan ; Heidi Cook-Andersen ; Kathleen M Fisch ; Soumen Paul ; Francesca SoncinSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe trophectoderm (TE), the outer layer of the blastocyst, is the first lineage specified during mammalian development. It initiates attachment and implantation into the maternal endometrium and gives rise to trophoblasts, the epithelial cells of the placenta that support development in utero. Animal models have identified key signaling pathways, including BMP, WNT, and HIPPO, that regulate extra-embryonic ectoderm development, but species-specific differences in regulatory networks underlying TE specification and placental development emphasize the need for human-specific models. We were the first to previously identify Vestigial-like Family Member 1 (VGLL1), a coactivator of the TEAD family of transcription factors, as a human-specific placental marker highly expressed in first trimester trophoblast progenitors. The HIPPO signaling pathway effector TEAD4 in complex with YAP1 regulates initial TE specification by acting on key TE transcription factors (TEtra factors): GATA2, GATA3, TFAP2A, and TFAP2C. Pluripotent stem cells (PSCs) represent a unique resource to study species-specific genetic and epigenetic mechanisms of TE and trophoblast development. Here, we use a PSC model in which BMP4 treatment and WNT inhibition (via IWP2) induce TE-like cells. We examined BMP4-dependent chromatin accessibility during the transition from PSC to TE-like cells in relation to gene expression and WNT activation. We found that BMP4 drives chromatin remodeling toward a trophoblast identity and that mesoderm genes are only transiently expressed with canonical WNT activation. Using this model, we determined that, while VGLL1 expression activation is temporally downstream of the TEtra factors, it is necessary for complete trophoblast differentiation by regulating EGFR expression and reinforcing GATA3 activation through positive feedback. We also found that VGLL1 enhanced canonical WNT signaling by directly regulating WNT receptors and effector genes. Furthermore, we identified KDM6B as a direct target of VGLL1. As a chromatin remodeler, KDM6B removes the ...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295126" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE295122 VGLL1 å¯¹å‘è‚²ä¸­çš„æ»‹å…»å±‚ç»†èƒçš„è½¬å½•ç»„å’Œè¡¨è§‚åŸºå› ç»„å‡æœ‰è´¡çŒ® [RNA-Seq 2]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ruben I Calderon ; Nirvay Sah ; Molly Huang ; Ryan H Kittle ; Walee B Shaik ; Jennifer N Chousal ; Sampada Kallol ; Tony Bui ; Robert Morey ; Alexandra Mitre ; Norah M Fogarty ; Claudia Gerri ; Claire Zheng ; Peter DeHoff ; Pratik Home ; Kathy K Niakan ; Heidi Cook-Andersen ; Kathleen M Fisch ; Soumen Paul ; Francesca SoncinSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe trophectoderm (TE), the outer layer of the blastocyst, is the first lineage specified during mammalian development. It initiates attachment and implantation into the maternal endometrium and gives rise to trophoblasts, the epithelial cells of the placenta that support development in utero. Animal models have identified key signaling pathways, including BMP, WNT, and HIPPO, that regulate extra-embryonic ectoderm development, but species-specific differences in regulatory networks underlying TE specification and placental development emphasize the need for human-specific models. We were the first to previously identify Vestigial-like Family Member 1 (VGLL1), a coactivator of the TEAD family of transcription factors, as a human-specific placental marker highly expressed in first trimester trophoblast progenitors. The HIPPO signaling pathway effector TEAD4 in complex with YAP1 regulates initial TE specification by acting on key TE transcription factors (TEtra factors): GATA2, GATA3, TFAP2A, and TFAP2C. Pluripotent stem cells (PSCs) represent a unique resource to study species-specific genetic and epigenetic mechanisms of TE and trophoblast development. Here, we use a PSC model in which BMP4 treatment and WNT inhibition (via IWP2) induce TE-like cells. We examined BMP4-dependent chromatin accessibility during the transition from PSC to TE-like cells in relation to gene expression and WNT activation. We found that BMP4 drives chromatin remodeling toward a trophoblast identity and that mesoderm genes are only transiently expressed with canonical WNT activation. Using this model, we determined that, while VGLL1 expression activation is temporally downstream of the TEtra factors, it is necessary for complete trophoblast differentiation by regulating EGFR expression and reinforcing GATA3 activation through positive feedback. We also found that VGLL1 enhanced canonical WNT signaling by directly regulating WNT receptors and effector genes. Furthermore, we identified KDM6B as a direct target of VGLL1. As a chromatin remodeler, KDM6B removes the ...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295122" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE298023 ä½ç½®å’Œç—…å› è°ƒèŠ‚è¡°ç«­äººç±»å¿ƒè„ä¸­çš„æˆçº¤ç»´ç»†èƒæ´»åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€gliomaã€TCGAã€scRNAã€scDNAã€scATACã€genomeã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Mohamad Youness ; Samaneh Ekhteraei-Tousi ; Rosa DoÃ±ate Puertas ; Chandan K Nagaraju ; Karin R Sipido ; Hywel L RoderickSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCardiac fibrosis is a major contributor to heart failure (HF), yet its therapeutic targeting remains limited due to the complexity of fibrosis types and distributions. This study investigates fibroblast heterogeneity and spatial organization in the left ventricle of human hearts from non-failing donors and HF patients with ischemic or dilated cardiomyopathy. Using single-nucleus RNA sequencing and spatial transcriptomics, distinct fibroblast subpopulations were identified, with resident fibroblasts being depleted in HF and replaced by disease-associated states. Differences in activation ligands, transcriptional trajectories, and spatial localization revealed divergent fibroblast transitions between scar and interstitial fibrosis, and between HF subtypes. These results provide insight into fibroblast dynamics and offer potential targets to modulate fibrosis in heart failure.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298023" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE246179 é•æš´éœ²çš®è‚¤è¡¨çš®çš„å•ç»†èƒåˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgliomaã€single.cellã€scRNAã€scDNAã€genomeã€genomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Kelvin YeungSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensIn this study, we investigated the consequences of repetitive nickel challenge at previously nickel-challenged skin sites in allergic participants. Repeated challenge with nickel resulted in progressive worsening allergic skin reactions in nearly all participants (11 out of 12). To investigate the immunopathogenesis of nickel in ACD, clinically cleared epidermal skin taken 21 days after each challenge was analyzed by immunohistochemistry, flow cytometry and single-cell RNA sequencing (scRNA-seq). Correlating with the worsening skin reactions, an expanding pool of epidermal CD4+ and CD8+ tissue-resident memory T (TRM) cells was seen locally in the challenged skin. Using scRNA-seq a broad subset of TRM cells with various effector phenotypes was identified, which included a predominant population of type 2 T helper (TH2) and KIR+CD8+ TRM cells that expanded with repeated challenge. We observed, broad clonal expansion after nickel challenge with interindividual variations, and clonally related clusters of less differentiated cells which may supply more developed effector TRM cells. Furthermore, repetitive challenge resulted in an increasing population of exhausted regulatory T (Treg) cells that showed lesser clonal expansion. Collectively, our data suggests that repeated challenge to nickel leads to aggravation of eczema and is supported by the increased numbers of effector TRM cells, phenotype differentiation, clonal expansion, and exhaustion of Treg cells in the challenged skin.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE246179" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE280244 ç”˜è‰æŸ¥å°”é…® B é€šè¿‡é¶å‘ FTO ç¼“è§£å…‹ç½—æ©ç—…æŸä¼¤</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€scRNAã€scDNAã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Duo Ma ; Xinhua Liu ; Yaling Hong ; Xingxing ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo investigate the mechanism of demethylase FTO in Crohn's diseaseï¼ŒWe used RNA-seq data from three normal colon samples and three TNBS-induced IBD colon samples of C57 mice for gene expression profiling.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280244" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE308590 å†…å«å­RNAç»“æ„å¯¹åŸºå› è¡¨è¾¾çš„æ§åˆ¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Leonard SchÃ¤rfen ; Pernille Bech ; Paulina PodszywaÅ‚ow-Bartnicka ; Karla M NeugebauerSeries Type : OtherOrganism : Saccharomyces cerevisiaeIntron removal through pre-mRNA splicing is a central step in gene expression across Eukarya. The process initiates with the recognition of intronic sequence elements (splice sites) by highly conserved RNA-protein components of the spliceosome. Intron sequences themselves are not generally conserved beyond the splice sites, yet intronic mutations are often associated with genetic disease. Here we systematically test if and how intron RNA structure formation modulates gene output. We generated intron variant libraries that measure the impact of base pairing at every position across a natural intron. Using a massively parallel reporter assay (MPRA), we find that base pairing involving the splice sites modulates splicing across orders of magnitude. An additional intron region upstream of the branch site was also sensitive to structure, suggesting steric hindrance. Combining thermodynamic structure prediction with libraries designed to sequester splice sites in structures of varying stability, we show that machine learning models can nearly fully explain observed gene output. Informed by this, designed alterations in intron sequence that modulate base pairing are shown to improve inefficient splicing of human Î²-globin IVS1. Finally, intronic mutations that alter RNA structure emerge rapidly under selection pressure, providing eukaryotes with a simple evolutionary strategy to fine-tune gene output.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308590" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE282578 ç»„è›‹ç™½å˜ä½“H2BEåœ¨å¤§è„‘ä¸­å…·æœ‰å¹´é¾„å’Œç»†èƒç±»å‹ç‰¹å¼‚æ€§æ•ˆåº”</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282578" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE190151 è“ç»¿è‰²é³‰é±¼å°¾é³RNAæµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNAseq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : David Willemsen ; Jongbeom Park ; Dario R ValenzanoSeries Type : Expression profiling by high throughput sequencingOrganism : Nothobranchius furzeriIn this study we investigated gene expression in tail fins of 12 samples. 3 samples from adult red-tailed male fish (MZCS002), 3 samples from adult yellow-tailed male fish (GRZ-BELL) and 3 samples each of the corresponding region in female fish of the same strain.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190151" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>scRNA</td>
<td>10</td>
</tr>
<tr>
<td>cancer</td>
<td>8</td>
</tr>
<tr>
<td>TME</td>
<td>8</td>
</tr>
<tr>
<td>scDNA</td>
<td>8</td>
</tr>
<tr>
<td>Seurat</td>
<td>7</td>
</tr>
<tr>
<td>glioma</td>
<td>6</td>
</tr>
<tr>
<td>genome</td>
<td>6</td>
</tr>
<tr>
<td>å•ç»†èƒ</td>
<td>5</td>
</tr>
<tr>
<td>TCGA</td>
<td>5</td>
</tr>
<tr>
<td>scATAC</td>
<td>5</td>
</tr>
<tr>
<td>histone</td>
<td>5</td>
</tr>
<tr>
<td>RNAseq</td>
<td>5</td>
</tr>
<tr>
<td>genomics</td>
<td>5</td>
</tr>
<tr>
<td>tumor</td>
<td>4</td>
</tr>
<tr>
<td>cardiac</td>
<td>4</td>
</tr>
<tr>
<td>DepMap</td>
<td>4</td>
</tr>
<tr>
<td>depmap</td>
<td>4</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>4</td>
</tr>
<tr>
<td>DNA-seq</td>
<td>4</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>4</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (6æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490480&amp;idx=1&amp;sn=190f2890fc4f4dc4c3f73ed8c8ad90bb" target="_blank" rel="noopener noreferrer">å•ç»†èƒæ•°æ®æ€ä¹ˆæŒ–æ˜å…³é”®åŸºå› </a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498461&amp;idx=1&amp;sn=47f4f6d237048428a22d249e0add22d4" target="_blank" rel="noopener noreferrer">åˆ†æPPIç½‘ç»œè¿™ä¹ˆç®€å•ï¼ŸPPInferåŒ…ï¼Œå¿«é€Ÿæ¨æ–­è›‹ç™½è´¨ç›¸äº’ä½œç”¨ï¼ŒåŠ©ä½ è½»æ¾æŒæ¡ç”Ÿç‰©ç½‘ç»œåˆ†æï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493117&amp;idx=1&amp;sn=aff254099727fb3a60efb2a7c0663f73" target="_blank" rel="noopener noreferrer">metasens åŒ…ç”¨äº metaåˆ†æä¸­çš„æ•æ„Ÿæ€§åˆ†æ:ç»“æœæŠ¥å‘Šåå€šä¸Šé™</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657285&amp;idx=2&amp;sn=1be9e36aea5d17d226e0425ce53a9bc8" target="_blank" rel="noopener noreferrer">å®æ³¢å¤§å­¦å¼ å‰ä¸½å›¢é˜ŸTrends in Parasitologyç»¼è¿°ä¸¨å¼“å½¢è™«æ„ŸæŸ“è¿‡ç¨‹ä¸­çš„ç»†èƒå…ç–«åº”ç­”ï¼šè§£è¯»ä¸åŒäººç¾¤å…ç–«å·®å¼‚</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509204&amp;idx=1&amp;sn=24004909faf364e603034040a825d5ee" target="_blank" rel="noopener noreferrer">é‡ç£…ç ”ç©¶ï¼é«˜åˆ†è¾¨ç‡è‚ºéƒ¨ç©ºé—´å•ç»†èƒå›¾è°±å‘å¸ƒï¼Œæ­ç¤ºç»†èƒåˆ†å¸ƒå¯†ç ä¸æ…¢é˜»è‚ºæ—©æœŸå˜åŒ–</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247489653&amp;idx=1&amp;sn=52d4f9e6eb5ed5eb1965e766de2dcc63" target="_blank" rel="noopener noreferrer">æŠ—è¡°è€ä¸ç”²åŸºåŒ–çš„å…³ç³»</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-09 21:36</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>